|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0008976,
umls-concept:C0016018,
umls-concept:C0019134,
umls-concept:C0019139,
umls-concept:C0031809,
umls-concept:C0034656,
umls-concept:C0036043,
umls-concept:C0040808,
umls-concept:C0155626,
umls-concept:C0205195,
umls-concept:C0206460,
umls-concept:C0542559,
umls-concept:C0872913,
umls-concept:C1879749
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2003-7-15
|
|
pubmed:abstractText |
The combination of a single-bolus fibrinolytic and a low-molecular-weight heparin may facilitate prehospital reperfusion and further improve clinical outcome in patients with ST-elevation myocardial infarction.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1524-4539
|
|
pubmed:author |
pubmed-author:AdgeyA A JAA,
pubmed-author:ArmstrongP WPW,
pubmed-author:ArntzH RHR,
pubmed-author:BogaertsKK,
pubmed-author:DanaysTT,
pubmed-author:GoldsteinPP,
pubmed-author:GrangerC BCB,
pubmed-author:LindahlBB,
pubmed-author:MäkijärviMM,
pubmed-author:Van de WerfFF,
pubmed-author:VerheugtFF,
pubmed-author:WallentinLL
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
15
|
|
pubmed:volume |
108
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
135-42
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12847070-Aged,
pubmed-meshheading:12847070-Cohort Studies,
pubmed-meshheading:12847070-Drug Therapy, Combination,
pubmed-meshheading:12847070-Emergency Medical Services,
pubmed-meshheading:12847070-Enoxaparin,
pubmed-meshheading:12847070-Female,
pubmed-meshheading:12847070-Hemorrhage,
pubmed-meshheading:12847070-Heparin,
pubmed-meshheading:12847070-Humans,
pubmed-meshheading:12847070-Injections, Intravenous,
pubmed-meshheading:12847070-Injections, Subcutaneous,
pubmed-meshheading:12847070-Male,
pubmed-meshheading:12847070-Middle Aged,
pubmed-meshheading:12847070-Myocardial Infarction,
pubmed-meshheading:12847070-Risk,
pubmed-meshheading:12847070-Safety,
pubmed-meshheading:12847070-Survival Analysis,
pubmed-meshheading:12847070-Thrombolytic Therapy,
pubmed-meshheading:12847070-Time Factors,
pubmed-meshheading:12847070-Tissue Plasminogen Activator,
pubmed-meshheading:12847070-Treatment Outcome
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Efficacy and safety of tenecteplase in combination with the low-molecular-weight heparin enoxaparin or unfractionated heparin in the prehospital setting: the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 PLUS randomized trial in acute myocardial infarction.
|
|
pubmed:affiliation |
Department of Cardiology and Uppsala Clinical Research Centre, Uppsala, Sweden. Lars.Wallentin@ucr.uu.se
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
